44 results
10-Q
2024 Q1
VS
Versus Systems Inc
15 May 24
Quarterly report
4:01pm
of revenues
Gross margin
EXPENSES
Research and development
Selling, general and administrative
Total operating expenses
Operating loss
Other income/(expense … to be sold. The costs incurred to establish the technological feasibility of the software that will be sold are expensed as research and development when
424B3
VS
Versus Systems Inc
29 Apr 24
Prospectus supplement
4:06pm
, manufacture and commercialize new products or achieve an acceptable return on our manufacturing or research and development efforts and expenses … considerable cost and effort in carrying out extensive research and development to assess the potential interest in our platform and to remain abreast
10-K
2023 FY
EX-19.1
VS
Versus Systems Inc
1 Apr 24
Annual report
2:07pm
, suppliers, or strategic partners on issues such as research and development, sales and marketing, and supply contracts;
employees, officers and directors
10-K
2023 FY
VS
Versus Systems Inc
1 Apr 24
Annual report
2:07pm
.
Research and Development
Our research and development team, including in-house and as-needed contract resources, consists of technical engineering … substantial resources in research and development to enhance our platform features and functionalities and expand the services we offer. We believe
S-4
k8h5paupcqmvpcgr
16 Feb 24
Registration of securities issued in business combination transactions
5:32pm
6-K
EX-99.2
7fnm2szur
14 Nov 23
Condensed Interim Consolidated Financial Statements
4:22pm
6-K
EX-99.2
dopzowh31 us
14 Aug 23
Condensed Interim Consolidated Financial Statements
4:01pm
6-K
EX-99.2
ac4qsvs5w3z
15 May 23
Condensed Interim Consolidated Financial Statements
4:05pm
6-K
EX-99.2
wck4s2k7jw qdkyi0
29 Mar 23
Consolidated Financial Statements
4:01pm
6-K
EX-99.2
d5crb i4hgm9d
14 Nov 22
Condensed Interim Consolidated Financial Statements
4:50pm
20-F/A
844kk111 t1k
23 Aug 22
Annual report (foreign) (amended)
4:15pm
6-K
EX-99.2
mt3kqbf4xd2grdinv4
15 Aug 22
Condensed Interim Consolidated Financial Statements
4:03pm
424B5
2vlsh
15 Jul 22
Prospectus supplement for primary offering
5:20pm
6-K
EX-99.2
r1q 24wa3l
16 May 22
Condensed Interim Consolidated Financial Statements
7:24pm
6-K
EX-99.2
glg fj85cnysywv5m47c
1 Apr 22
Consolidated Financial Statements
9:10pm
424B4
v7hossf3jk6 o4
24 Feb 22
Prospectus supplement with pricing info
4:02pm
POS AM
foa6yoj02rz zcce
1 Feb 22
Prospectus update (post-effective amendment)
5:29pm